Skip to main content

Abstract

In 1944, Waldenström described a new syndrome in three patients who presented with a variety of haemorrhagic and ocular disorders associated with marked increases in both serum viscosity and in a serum globulin which had a very high molecular weight on ultracentrifugation; an underlying lymphoproliferative disorder involving the bone marrow was subsequently found in all three patients. In a recently published study of 40 cases of Waldenström’s macroglobulinaemia (WM), one-third of the patients had clinical evidence of this hyperviscosity syndrome, (Mackenzie and Fudenberg, 1972). Some authors (Fahey et al., 1965; Mackenzie et al., 1970) have claimed that individual patients have a threshold value for blood viscosity above which they become symptomatic, while others (Pronk et al., 1969) could find no clear relation between either serum viscosity or paraprotein level and the clinical symptomatology. There is a similar divergence of opinion on the relation between IgM level and viscosity. Some workers have found a highly significant linear correlation between serum viscosity and IgM (Somer, 1966; 1975; Rosenblum and Asofsky, 1968), yet others have found a steep non-linear increase in serum viscosity, particularly with IgM levels above 40 g/litre (Preston et al., 1978). This discrepancy may in part be explained by the observation of Mackenzie and Babcock (1975) that a steep non-linear relationship is found in patients whose monoclonal paraprotein is markedly asymmetrical in configuration, while those with a more normal spheroidal IgM tend to exhibit a linear relationship. In our experience, there is a highly significant linear correlation between whole-blood viscosity and IgM level, at least up to 40 g/litre paraprotein (Fig. 20.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Barth W F, Wochner R D, Waldmann T A, Fahey J L (1964) Metabolism of human gamma macro-globulins. J Clin Invest 43: 1036–1048

    Article  PubMed  CAS  Google Scholar 

  • Begg T B, Hearns J B (1966) Components in blood viscosity. The relative contribution of haematocrit, plasma fibrinogen and other proteins. Clin Sci 31: 87–93

    PubMed  CAS  Google Scholar 

  • Buskard N A, Galton D A, Goldman J M, Kohner E M, Grindle C F, Newman D L, Twinn K W, Lowenthal R M (1977) Plasma exchange in the long term management of Waldenström’s macroglobulinaemia. Can Med Assoc J 117: 135–137

    PubMed  CAS  Google Scholar 

  • Cokelet G R (1963) The rheology of human blood. Doctoral dissertation. M.I.T., Cambridge, Mass. Fahey J L, Barth W F, Solomon A L (1965) Serum hypersensitivity syndrome. JAMA 192: 464–467

    Google Scholar 

  • Hobbs J R (1969) Immunochemical classes of myelomatosis. Br J Haemat 16: 599–606

    Article  CAS  Google Scholar 

  • Mackenzie M R, Babcock J (1975) Studies of the hyperviscosity syndrome. 2. Macroglobulinaemia. J Lab Clin Med 85: 227–234

    CAS  Google Scholar 

  • Mackenzie M R, Brown E, Fudenberg H H, Goodenday L (1970) Waldenström’s macroglobulinaemia. Correlation between expanded plasma volume and increased serum viscosity. Blood 35: 394–408

    PubMed  CAS  Google Scholar 

  • Mackenzie M R, Fudenberg H H (1972) Waldenström’s macroglobulinaemia. An analysis of forty patients. Blood 39: 874–889

    PubMed  CAS  Google Scholar 

  • Preston F E, Cooke K B, Foster M E, Winfield D A, Lee D (1978) Myelomatosis and the hyperviscosity syndrome. Br J Haematol 38: 517–530

    Article  PubMed  CAS  Google Scholar 

  • Pronk E A S, Klein F, Elkerbout F, Radema H, Cleton F J (1969) Therapy of macroglobulinaemia. Acta Med Scand 186: 273–281

    Article  PubMed  CAS  Google Scholar 

  • Rosenblum W I, Asofsky R M (1968) Factors affecting blood viscosity in macroglobulinaemic mice. J Lab Clin Med 71: 201–211

    Google Scholar 

  • Somer T (1966) The viscosity of blood, plasma and serum in dys-and paraproteinaemias. Acta Med Scand Suppl 456: 1–97

    CAS  Google Scholar 

  • Somer T (1975) Hyperviscosity syndrome in plasma cell dyscrasias. Adv Microcirc 6: 1–55 Waldenström J (1944) Incipient myelomatosis or “essential” hyperglobulinaemia with fibrinogenopenia — a new syndrome? Acta Med Scand 117: 216–247

    Google Scholar 

  • Weaver J P A, Evans A, Walder D N (1969) The effect of increased fibrinogen content on the viscosity of blood. Clin Sci 36: 1–10

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Spring-Verlag Berling Heidelberg

About this paper

Cite this paper

Allan, T.L. (1981). Plasma Exchange in Macroglobulinaemia. In: Lowe, G.D.O., Barbenel, J.C., Forbes, C.D. (eds) Clinical Aspects of Blood Viscosity and Cell Deformability. Springer, London. https://doi.org/10.1007/978-1-4471-3105-2_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3105-2_20

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-3107-6

  • Online ISBN: 978-1-4471-3105-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics